Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2026
Revenue$1.5 billion+9% YoY
EPS$2.64
Earnings release · RMD
Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2027
Resmed Inc. · Filed · SEC Form 8-K, Item 2.02
Revenue
$1.4 billion
+6% vs a year ago
EPS
$2.92
not detected
Guidance
—none detected
Automated extract. The items below were picked out of the company's press release by software and may be wrong or incomplete.
Please read the original before relying on any figure. Not investment advice.
Why it matters
Revenue rose 6% year on year to $1.4 billion, and EPS was $2.92. Year-on-year revenue change of +6% was weaker than the +9% in the company's previous release (filed August 2026).
Written automatically by Stocknote's note engine from the figures on this page and the company's previous release. Every number in this note is checked against those figures. Not investment advice.
What the company states
Revenue
$1.4 billion +6% vs a year ago
…Q1 revenue increased by 6% to $1.4 billion; up 7% on a core constant currency basis…
EPS
$2.92
…Q1 GAAP diluted earnings per share up 23% to $2.92; non-GAAP diluted EPS up 14% to $2.91…
Guidance
No guidance statement detected
Compared with the previous report
Aug 6, 2026 →| Previous (Aug 6) | This release | Change | |
|---|---|---|---|
| Revenue growth (YoY) | +9% | +6% | −3.0 pts |
| EPS growth (YoY) | — | — | — |
| Guidance | — | — | — |
“pts” = percentage points of year-over-year growth, current release minus previous release.
Trend: last 2 reports
All releases →Other releases from Resmed Inc.
All →
Disclaimer: This page is generated automatically from public SEC filings for information only. Stocknote does not edit the company's release and does not guarantee the accuracy of the extracted items. Read the full disclaimer here.